Check out how we utilize the modularity of the Pin-point™ platform, the aptamer-recruited base editing system, to introduce multiple discrete modifications simultaneously, including targeted integration, and to create complex edited cell therapies in one-step process. Our paper is now published in #MolecularTherapy https://lnkd.in/dEh3g92r
Immacolata Porreca’s Post
More Relevant Posts
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
Sr. Global Marketing Leader, Cell & Gene Therapy, Protein Expression at Thermo Fisher Scientific
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
Technical Sales Specialist Middle East at Thermo Fisher Scientific | Customer centric advocate to make the world healthier, cleaner and safer
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
Senior Global Market Development Manager, Cell and Gene Therapy at Thermo Fisher Scientific
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
-
The clinical drug development market is teeming with innovation, including cell and gene therapies, digital therapeutics, personalized medicine and biomarkers, and the integration of drugs and medical devices. However, despite these breakthroughs, many life sciences organizations are not able to fully capitalize on the advancements. Does your organization possess the advanced digital and data capabilities to harness the new trial designs and operating models that will increase program efficiency, speed, and access? Read our Point of view 👇 https://bit.ly/48ArUK7 #lifesciences #clinicaldevelopment #Innovation #nextgenclinicaldevelopment
-
The clinical drug development market is teeming with innovation, including cell and gene therapies, digital therapeutics, personalized medicine and biomarkers, and the integration of drugs and medical devices. However, despite these breakthroughs, many life sciences organizations are not able to fully capitalize on the advancements. Does your organization possess the advanced digital and data capabilities to harness the new trial designs and operating models that will increase program efficiency, speed, and access? Read our latest POV 👇https://bit.ly/3SKtKT1 #LifeSciences #ClinicalDevelopment #Innovation #nextgenclinicaldevelopment
-
Global Market Development Manager for Cell & Gene Therapy, Women Empowerment Advocate & Community Builder
🌟Join us for an insightful webinar🌟"Optimizing for the Future: Streamlining the Production of T Cell-Based Immunotherapies" Register here: https://lnkd.in/gxS6t9wB 🗓 Date: Wednesday, October 30 🕗 Time: 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET #CellTherapy #GeneTherapy #Immunotherapy #Webinar #Innovation #Biotech #Healthcare 🎯 Key Takeaways: 1. Understand the significance of closed, automated cell therapy manufacturing workflows supported by modular instruments, enabling flexible process development and cost-efficient scale-up and scale-out. 2. Discover case studies on industry collaborations aimed at scaling, simplifying, and expediting cell therapy manufacturing, including a lentivirus-mediated, 5 to 7-day process for optimizing transduction efficiency in CAR-T production. 3. Learn about a shortened 24-hour, GMP-compliant process to enhance efficiency in CAR-T manufacturing workflows. The field of cell and gene therapy is advancing rapidly, yet manufacturing challenges remain, with current processes being complex, labor-intensive, and susceptible to contamination and errors. In this webinar, industry experts will discuss how closed, automated cell processing systems with validated protocols and GMP-compliant raw materials can address these challenges. Additionally, the importance of strategic industry partnerships in driving innovation and commercialization will be highlighted. Read our Cell Therapy Handbook for more information: https://lnkd.in/gSumucQj
-
Assistant Professor, Department of Cancer Biology and Genetics; Director, Gene Editing Shared Resource presso The Ohio State University Wexner Medical Center
4moSo cool!!